Cuprindo

N/A

Report date: 2022/02/18 15:46:16

NME

Base Information

Drug NameCuprindo

Drug Alias Nameindomethacin copper-complex

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionCyclooxygenases inhibitors

TargetsCyclooxygenases

Therapy Area/IndicationsInflammation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesCellmid

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesCellmid

Active IndicationsN/A

Inactive IndicationsInflammation

ATC CodeN/A